Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
DNLI —
DENALI THERAPEUTICS INC
CUSIP: 24823R105 · Held by 3 superinvestors · Combined value: $13,931,930
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $13,311,154 | 806,248 | ADD | +106,424 |
| 2 | Polen Capital | 0.0% | $444,119 | 26,900 | NEW BUY | +26,900 |
| 3 | Jim Simons | 0.0% | $176,657 | 10,700 | REDUCE | -49,100 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Polen Capital | NEW BUY | +26,900 | New |
| Ken Griffin | ADD | +106,424 | +15.2% |
| Jim Simons | REDUCE | -49,100 | -82.1% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | REDUCE | -135,900 | -69.4% |
| Ken Griffin | REDUCE | -584,929 | -45.5% |
Who Owns DNLI? Superinvestor Holdings
DENALI THERAPEUTICS INC is held by 3 tracked superinvestors, with a combined position value of $14 million . The largest positions are held by Ken Griffin (0.0% of portfolio), Polen Capital (0.0% of portfolio), Jim Simons (0.0% of portfolio).
In the most recent quarter, 2 superinvestors added or initiated positions while 1 reduced or exited.